Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Hajime, Kageyama"'
Autor:
Nobukiyo Yoshida, Hajime Kageyama, Hiroyuki Akai, Koichiro Yasaka, Haruto Sugawara, Yukinori Okada, Akira Kunimatsu
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274576 (2022)
Voxel-based specific region analysis systems for Alzheimer's disease (VSRAD) are clinically used to measure the atrophied hippocampus captured by magnetic resonance imaging (MRI). However, motion artifacts during acquisition of images may distort the
Externí odkaz:
https://doaj.org/article/e876da20867642f5bc59c67a2048f18c
Autor:
Hiroto Fujita, Keita Ueda, Hajime Kageyama, Tomoyuki Shiozaki, Hiroshi Inui, Tadashi Kitahara
Publikováno v:
Auris Nasus Larynx.
Autor:
Hideki Kimura, Hiroyuki Mano, Ichiro Yoshino, Toshihiko Iizasa, Makiko Itami, Kengo Takeuchi, Manabu Soda, Hajime Kageyama, Dai Ikebe, Kazuhiro Yasufuku, Takahiro Nakajima, Yuichi Sakairi
Purpose: Anaplastic lymphoma kinase (ALK) fusion genes represent novel oncogenes for non–small cell lung cancers (NSCLC). Several ALK inhibitors have been developed, and are now being evaluated in ALK-positive NSCLC. The feasibility of detecting AL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::062f1110eddba07d6d23d50cfb084a02
https://doi.org/10.1158/1078-0432.c.6519078
https://doi.org/10.1158/1078-0432.c.6519078
Publikováno v:
Leukemia & Lymphoma. 60:493-497
Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma (ALK + LBCL) is a rare subtype of lymphoma defined as a neoplasm of ALK-positive large immunoblast-like B-cells, with occasional plas...
Genomic Analysis of Diffuse Large B Cell Lymphoma in a Japanese Cohort Using Targeted DNA Sequencing
Autor:
Atsushi Kaneda, Yusuke Takeda, Osamu Ohara, Hideki Tsujimura, Hajime Kageyama, Naoya Mimura, Shio Mitsukawa, Masahiro Takeuchi, Emiko Sakaida, Koutaro Yokote, Masaki Fukuyo, Tohru Iseki, Kensuke Kayamori, Chikako Ohwada, Bahityar Rahmutulla, Chiaki Nakaseko, Tomoya Muto, Tatsuzo Mishina, Yutaro Hino, Yurie Nagai, Jun-ichiro Ikeda, Makiko Itami, Shokichi Tsukamoto, Nagisa Oshima-Hasegawa
Publikováno v:
Blood. 136:14-15
Introduction: Recent studies based on next-generation sequencing revealed the genetic landscape of diffuse large B cell lymphoma (DLBCL). A new genetic classification system was proposed, including four groups; the BCL2 and SGK1 groups that were both
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
Follicular lymphoma (FL) is genetically characterized by BCL2/IGH translocation. Some FL cases histologically transform to high-grade lymphoma, and the majority of cases transform to diffuse large B-cell lymphoma. We report herein an unusual FL case
Autor:
T. Setoguchi, Sana Yokoi, Miki Ohira, Makiko Itami, Hajime Kageyama, Takahiro Sugiyama, Toshihiko Iuchi, Yuzo Hasegawa, T. Sakaida
Publikováno v:
Brain tumor pathology. 35(2)
In this study, we retrospectively compared the prognostic value of the 2016 WHO classification with the former classification in 387 patients with glioma treated at our institution. According to the new classification, diagnoses included oligodendrog
Autor:
Toshihiko Iuchi, Junji Hosono, Gentaro Togasaki, Takahiro Sugiyama, Ryusuke Hara, T. Sakaida, T. Setoguchi, Yuzo Hasegawa, Akio Higuchi, Makiko Itami, Hajime Kageyama
Publikováno v:
Neuro-oncology Advances
PURPOSE/OBJECTIVE The molecular responses of glioblastomas (GBMs) to hypofractionated IMRT/TMZ were investigated to elucidate the molecular targets included in the resistance of these tumors to chemo-radiation therapy. MATERIALS /METHODS Phase I stud
Autor:
Makiko Itami, T. Setoguchi, Ryusuke Hara, Toshihiko Iuchi, Kazuo Hatano, T. Sugiyama, T. Sakaida, T. Gentaro, Hajime Kageyama, Yuzo Hasegawa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:E638
Autor:
Yuzo Hasegawa, T. Sakaida, Toshihiko Iizasa, O. Nagano, Sana Yokoi, Hajime Kageyama, K. Kawasaki, Masato Shingyoji, Kazuo Hatano, Meiji Itakura, Toshihiko Iuchi
Publikováno v:
Lung Cancer. 82:282-287
Background Brain metastases (BM) are a common in patients with lung cancer. Although whole-brain radiation therapy (WBRT) is the standard therapy, it may have a risk of decline in cognitive function of patients. In this study, we evaluated the effica